Search - tctmd.com

Displaying 1 - 20 of 101

Sort: Relevancy | Date

Presentation TCT 2025

Right Heart Physiology and RV Dsyfunction: Determinants of Clinical Outcomes in TR Patients

Presenter: JoAnn Lindenfeld

October 28, 2025

Presentation TCT 2025

Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs. HFpEF Presented

Presenter: JoAnn Lindenfeld

October 27, 2025

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

Presentation NY Valves 2025

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Presenter: JoAnn Lindenfeld

June 25, 2025

Presentation THT 2025

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Presenter: JoAnn Lindenfeld

February 13, 2025

Presentation THT 2025

Interatrial Shunts and the HFrEF - HFpEF Divide: The Differential Effects in RELIEVE-HF Explained?

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

Presenter: JoAnn Lindenfeld

February 12, 2025

Presentation THT 2025

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

Presenter: JoAnn Lindenfeld

February 11, 2025

Presentation TCT 2024

How To Select the Most Appropriate SMR Patients For M-TEER?

Presenter: JoAnn Lindenfeld

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

Presentation TCT 2024

Overview of IASD Trials: Where Do We Stand?

Presenter: JoAnn Lindenfeld

October 28, 2024

Presentation NY Valves 2024

TTVI in in the Failing Right Heart

Presenter: JoAnn Lindenfeld

June 07, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation THT 2024

The Conundrum of Clinical Trials in Cardiogenic Shock

Presenter: JoAnn Lindenfeld

March 06, 2024

Presentation THT 2024

Long-term Results of the BeAT-HF Clinical Study

Presenter: JoAnn Lindenfeld

March 05, 2024

Presentation THT Abstracts 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

Presentation TCT 2023

The Importance of Optimizing Medical Therapy in Patients Undergoing Coronary and Structural Interventional Procedures

Presenter: JoAnn Lindenfeld

October 26, 2023

Advertisement

Right Heart Physiology and RV Dsyfunction: Determinants of Clinical Outcomes in TR Patients

Mechanistic Basis for Differential Effects of Interatrial Shunt Treatment in HFrEF vs. HFpEF Presented

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

A Treatment Algorithm for GDMT in FMR Patients (Including ‘Dynamic’ MR)

Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?

Interatrial Shunts and the HFrEF - HFpEF Divide: The Differential Effects in RELIEVE-HF Explained?

Pulmonary Artery Diastolic Pressure Is Lower in Women Than Men Preceding and at the Time of Heart Failure Hospitalization

Pills, Drips and Pumps: Management of Volume Status and RV Dysfunction Before and After TTVI

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

How To Select the Most Appropriate SMR Patients For M-TEER?

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Overview of IASD Trials: Where Do We Stand?

TTVI in in the Failing Right Heart

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

The Conundrum of Clinical Trials in Cardiogenic Shock

Long-term Results of the BeAT-HF Clinical Study

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

The Importance of Optimizing Medical Therapy in Patients Undergoing Coronary and Structural Interventional Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content